Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 4:13:32.
doi: 10.1186/1472-6947-13-32.

Evaluation of a drug-drug interaction: fax alert intervention program

Affiliations

Evaluation of a drug-drug interaction: fax alert intervention program

Edward P Armstrong et al. BMC Med Inform Decis Mak. .

Abstract

Background: Clinicians often encounter information about drug-drug interactions (DDIs) during clinical practice. This information is found within product information (hardcopy and electronic) and various electronic systems. Prescribers may receive medication-related communications in practice that are distributed by facsimile (fax), mail, or telephone from pharmacies and pharmacy benefit managers (PBMs). The purpose of this study was to determine if near-real time fax alerts for potential drug-drug interactions (PDDIs) would influence prescribing.

Methods: A prospective study, in cooperation with a pharmacy benefit manager (PBM), was conducted targeting 18 clinically important PDDIs. Fax alerts included an individualized letter to the prescriber with a list of the interacting drugs, PDDI evidence summaries with citations, and recommended clinical management strategies. Among the 18 PDDIs, 13 PDDIs could be assessed for prescription therapy changes using pharmacy claims data. A prospective cohort design was used to evaluate changes in prescription dispensing 90-days following a PDDI fax alert.

Results: A total of 8,075 fax alerts were sent to prescribers and there were 4,712 alerts for the 13 PDDIs that could be assessed for change using pharmacy claims data. There were 2,019 patients (interventions) for which fax alerts were sent to their prescribers who were matched with a control group consisting of patients with the same PDDIs but for whom no fax alert was sent. Overall, this study found 154 (7.6%) of patients in the fax alert group compared to 132 (6.5%) in the control group had changes in therapy (p = 0.177).

Conclusions: This fax alert intervention program observed no statistically significant differences in prescribing with a fax alert compared to the control group. If PBMs chose to send individualized, evidence-based information to clinicians regarding drug-drug interactions, this study suggests it may not be an effective intervention to mitigate harm.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Soumerai SB, Lipton HL. Computer-based drug-utilization review–risk, benefit, or boondoggle? N Engl J Med. 1995;332(24):1641–1645. doi: 10.1056/NEJM199506153322411. - DOI - PubMed
    1. Lyles A, Sleath B, Fulda TR, Collins TM. Ambulatory drug utilization review: opportunities for improved prescription drug use. Am J Manag Care. 2001;7(1):75–81. quiz 82-73. - PubMed
    1. Curtiss FR, Fairman KA. Quality improvement opportunities in prescriber alert programs. J Manag Care Pharm. 2010;16(4):292–296. - PMC - PubMed
    1. Armstrong EP, Malone DC, Hines LE, Wang SM, Patel BV. Evaluation of prescriber perceptions of a near-real time fax alert progdram for potential drug-drug interactions. Value in Health. 2012;15:A28. abstract. - PMC - PubMed
    1. Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Bergen RC, Duncan-Edgar BS, Solomon SL, Lipton RB. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc. 2004;44(2):142–151. doi: 10.1331/154434504773062591. - DOI - PubMed

Publication types